Loading clinical trials...
Loading clinical trials...
Clinical Effect and Tolerability of Atorvastatin Versus Placebo in Patients With Pulmonary Hypertension: Double-blinded, Randomised, Prospective Phase II Study for 6 Months With Adjusted Doses of Atorvastatin
Conditions
Interventions
Atorvastatin
Placebo
Locations
1
China
Cardiovascular Institute and Fu Wai Hospital
Beijing, Beijing Municipality, China
Start Date
February 1, 2007
Primary Completion Date
March 1, 2010
Completion Date
May 1, 2010
Last Updated
February 23, 2012
NCT07079592
NCT05719415
NCT07039604
NCT03388476
NCT01065454
NCT04732221
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions